Pharmaceutical preparations company · DE · FY ends Dec · -$54M FCF
ROIC dropped from -18.77% to -27.39%, capital efficiency is deteriorating. Negative free cash flow of -$55M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
Net Income (TTM)
-$70M
▼ -40.7% YoY
Op. Margin
—
ROIC
-29.23%
▼ -8.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$54M
▼ -25.6% YoY
Op. Cash Flow (TTM)
-$54M
▼ -26.1% YoY
Net Debt
-$220M
Net Cash Position
Cash & Equiv.
$223M
Continue Research